Literature DB >> 6991323

Continuous subcutaneous infusion of insulin in the management of diabetes mellitus.

M C Champion, G A Shepherd, N W Rodger, J Dupre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6991323     DOI： 10.2337/diab.29.3.206

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  21 in total

Review 1.  Recent developments in insulin delivery techniques. Current status and future potential.

Authors:  F P Kennedy
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

2.  Continuous subcutaneous insulin infusion: a long-term study.

Authors:  A Lombardo; S Scavino; G Scornavacca; G Oliva; C Sipione; R Cacciola; L Motta
Journal:  Acta Diabetol Lat       Date:  1986 Jan-Mar

3.  A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 2. Marked attenuation of the metabolic deterioration by somatostatin.

Authors:  A J Scheen; G Krzentowski; M Castillo; P J Lefèbvre; A S Luyckx
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

4.  Pharmacokinetic approach for reconstruction of predetermined plasma insulin profiles by continuous subcutaneous insulin infusion in depancreatized dogs.

Authors:  H Hirayama; Y Kasuya; T Kobayashi; T Itoh; A Yagishita; T Katakura; K Isono
Journal:  J Pharmacokinet Biopharm       Date:  1983-12

Review 5.  Technology and the diabetic patient.

Authors:  J C Pickup; D Rothwell
Journal:  Med Biol Eng Comput       Date:  1984-09       Impact factor: 2.602

6.  Continuous subcutaneous insulin infusion (CSII) in insulin-dependent diabetes.

Authors:  M Varghese; K Walshe; P M Bell; D R Hadden; A L Kennedy; J A Weaver
Journal:  Ir J Med Sci       Date:  1983-02       Impact factor: 1.568

Review 7.  Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.

Authors:  E W Kraegen; D J Chisholm
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

8.  Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion.

Authors:  J C Pickup; G C Viberti; R W Bilous; H Keen; K G Alberti; P D Home; C Binder
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

9.  The effect of continuous subcutaneous insulin infusion and conventional insulin regimes on 24-hour variations of blood glucose and intermediary metabolites in the third trimester of diabetic pregnancy.

Authors:  J M Potter; J P Reckless; D R Cullen
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

10.  Insulin responses to varying profiles of subcutaneous insulin infusion: kinetic modelling studies.

Authors:  E W Kraegen; D J Chisholm
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.